Pierre VÉronneau
Non-Executive Director
pharmaceutical
Luqa Pharmaceuticals
China
Biography
Pierre Véronneau is a member of Luqa Pharmaceuticals board of Directors since 2012. Pierre has an established experience base which stretches across the major markets of the world through his career as a consulting strategist and as a business developer or with the pharmaceutical companies Almirall and DuPont. At Almirall, he spearheaded the Licensing and M&A strategy of the company up to the end of 2010. Under his serial licensor leadership, a first ever, transformational, Pan-EU license was secured plus several other important deals were signed. Prior to this role, he was the first General Manager of Almirall¹s newly acquired inhalation technology R&D centre in Germany. When joining the company in 2002, he led a small group of talented licensing professionals, closing deals on 4 continents and managing over 60 partnerships.
Research Interest
pharmaceutical
